76Bio
New York · Founded 2020
About 76Bio
76Bio is a biotechnology company that develops therapies for patients with life-threatening diseases. It specializes in pioneering targeted protein degraders. The company was founded in 2020 and is based in New York.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.0M
- Last round: Series Unknown (Jan 2022)
- Website: https://www.76bio.com
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/76bio-87001 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.